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Clinical and pathological studies on cryptogenic organizing pneumonitis (COP) were performed in 19 cases 
diagnosed with transbronchial lung biopsy (TBLB). All patients suffered from fever and several respiratory 
symptoms. Laboratory data showed increases in erythrocyte sedimentation rate, positivity for C-reactive 
protein, negative tuberculin reactions and increases in complement level. Pathological findings demonstrated 
that there were two kinds of organizing processes. Fourteen of the 19 cases were treated with prednisolone, 
and two cases were observed without administration. The remaining three cases could not be followed up after 
therapy. In 11 of the 16 cases, abnormal shadows in chest X-ray disappeared, but remained present in five 
cases. As for the relationship between pathological findings and shadows in chest X-ray, Masson bodies 
without fibrin were observed in the 11 cases which were without shadows on X-ray, but Masson bodies 
containing or related to fibrin were observed in the five cases in which abnormal shadows remained. 
These results suggest that there are two types of organizing process in COP. Type I is an unexplained 
organizing process in which fibrin is not present or involved. It responds well to steroids and the prognosis is 
favourable. Type II is an organizing process which involves fibrin, and the character of the fibroblast-like cells 
is very similar to that of myofibroblasts. Type II organizing process responds poorly to steroids. Both 
processes can be notified relatively easily, even by TBLB tissues. 
Introduction 
Recently, many patients with pneumonia show 
poor resolution of chest shadows and require differ- 
entiation from other diseases. In such patients, trans- 
bronchial lung biopsy (TBLB) often reveals 
organization in the alveoli. The aetiology is generally 
unknown. This has been designated as cryptogenic 
organizing pneumonitis (COP) (1) and bronchiolitis 
obliterans organizing pneumonia (BOOP) (2). To 
explain this clinical phenomenon by comparison with 
pathologic findings, 19 cases which were diagnosed 
as COP by TBLB were evaluated clinically and 
pathologically. 
Materials and Methods 
The 19 subjects were patients who had been admit- 
ted with pulmonary involvement of the pneumonia 
type, but did not respond to antibiotics and were 
shown to have organizing pneumonia (OP) histologi- 
cally by TBLB between January 1989 and December 
1992. In these patients, no response was observed to 
various antibiotics and the cause of the disease was 
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serologically and clinicopathologically unknown. 
The characteristics of these patients, signs and symp- 
toms, results of clinical laboratory tests, pathologic 
findings of TBLB specimens and therapeutic results 
were evaluated. The material obtained by TBLB 
was fixed with buffered formalin and stained with 
HE. Additional phosphotungstic acid-haematoxylin 
(PTAH), Azan, Elastic van Gieson (EVG), and 
Alcian blue staining were made depending on the 
case. Also, to clarify the properties of cells prolifer- 
ating in Masson bodies, deparaffinized sections 
were studied using immunostaining by the avidin- 
biotin complex (ABC) method with peroxidase. 
Anti-macrophage, anti-muscle-actin (m-actin) (Enzo 
Diagnostics Inc., U.S.A.), anti-epithelial membrane 
antigen (EMA), anti-vimentin, anti-desmin 
(Dakopatts, Denmark), and anti-u-smooth muscle- 
actin (a-sm-actin) (BioMaker, Israel) antibodies were 
used. Histological findings were examined in Masson 
bodies, alveoli and interalveolar septa. Fibrin in 
Masson bodies, fibroblasts, alveolar macrophages, 
type II alveolar epithelium, oedema of interalveolar 
septa, fibrosis, and inflammatory cell infiltration were 
graded as - , +, and + +, and their correspondence 
with clinical findings was evaluated. 
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Table 1 Clinical features 
Case Age PO* PCO, Therapy Chest X-ray shadows 
No. W Sex Fever Cough Sputum Dyspnoea (mmHg) (mmHg) (PSLmg) after therapy 
1 70 M + + + + 19.4 426 Pulse 1 
2 86M+ - - + 53.1 36.3 60 D 
3 89M + - - + 61.4 40.1 60 1 
4 95 M + + + + 48.9 28.6 Pulse . 1 
5 61 M - - - + 75.9 3.59 20 D 
6 62 F + + + + 71.4 344 60 D 
I 58 M + + + - 76.9 45.8 30 I 
8 73 M + + + - 74.0 34.5 60 D 
9 88 M + + 
10 75 M - - z 
- 
- 
11 61 M + + - - 15 D 
12 64 F + + - - 20 D 
13 34 F - + + - 0 D 
14 63 M + + + - 71.3 36.3 0 D 
15 12 M + + + + 55.8 42.8 Pulse I 
16 77 F + + + + 56.5 39.2 60 D 
17 70 M + + + - Pulse D 
18 62 M + + + - 14.7 38.5 
19 54 F + + + - 20 D 
+, present; - , absent; D, disappeared; I, improved but not disappeared. 
Table 2 Laboratory data* 
Case ESR CRP LDH ChE 
No. WBC (mm hr- ‘) (mg dll’) (IU 1-l) (dpH) (g d:p-‘) (k?‘) (WI%‘) ANF 
PPD I@ 
test (mg dl~ ‘) 
1 5500 115 0 218 0.69 7.8 64.0 
2 7900 76 6.0 245 0.38 5.7 46.6 - 
3 6600 75 9.6 295 0.39 5.9 31.6 - 
4 7100 38 13.5 353 0,53 4.8 39.8 34 
5 5600 91 17.9 369 1.03 6.3 59.9 - 
6 9600 102 3.0 243 0.50 6.4 65.0 - 
7 15 900 88 10.1 245 0.38 5.8 44.9 
8 6100 115 11.2 293 064 7.3 65.0 - 
9 5800 18 2.0 323 0.35 6.3 37.0 - 
10 3000 42 4.0 396 0.52 6.1 
11 5100 78 15.1 237 0.40 6.1 - 
12 8900 54 9.9 322 0.61 6.2 45.7 - 
13 5600 96 2.9 210 0.97 7.4 32.5 - 
14 9300 98 5.9 324 0.29 7.1 37.8 31 
15 9900 129 26.1 382 0.45 5.7 - 
16 7400 95 5.1 303 0.63 6.8 44.9 - 
17 6600 72 4.2 363 0.58 7-6 - 
18 10 600 130 6.9 353 0.63 6.6 31.7 - 
19 13 300 112 13.6 322 1.14 8.3 55.4 - 
985 
2606 
864 
1270 
1320 
1372 
2380 
1700 
1570 
1690 
2043 
2575 
1845 
2128 
*Abbreviations see text. 
+, positive result; - , negative result. 
Results plaints, some respiratory symptoms were observed in 
As shown in Table 1, the patients were aged 39-95 all patients, and fever was noted in 16 of the 19 
years with a mean of 69.5 years. They consisted of 14 patients. Dyspnoea was present in eight patients. 
males and five females. Concerning the primary com- Table 2 summarizes the results of laboratory tests on 
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Table 3 Pathological findings 
Masson bodies Alveoli Septa 
Case Spindle Lining Macro- 
Type II cells 
Macro- Inflammatory 
No. Fibrin cells alveolar cells phages Proliferation Swelling phages Oedema Fibrosis cells 
1 ++ + - + + + + - + + 
2 - ++ + + ii- + - - + - 
3 ++ ii - + - - + + + - 
4 + ++ + + + + + + + + 
5 - ++ + + + + ++ - + - 
6 - + + + + - + - ++ + 
7 + 4-i + + + - + + + + 
8 - i--k + + ++ - + + + + 
9 - ++ + - - + ++ + ++ + 
10 - + - - - - - - - - 
11 - ++ + - + ++ + - - - 
12 - + - - + - + - + + 
13 - ++ + - + - + + + + 
14 - + - + ++ + + f + + 
15 ++ + + ++ + + + + ++ ++ 
16 - + + ++ + + + - + + 
17 - + - + - - + + - + 
18 - + - + - - + + - + 
19 - + + + + - + + - + 
+, + +, present to lesser, greater extent; - , absent. 
admission. The white blood cell count (WBC) ranged 
from 3000-15 900 with a mean of 7884. Leucocytosis 
was only noted in five patients. Erythrocyte sedimen- 
tation rate (ESR) and C-reactive protein (CRP), on 
the other hand, were increased in all patients but one. 
Concerning biochemical examinations, GOT, GPT, 
and LDH were within the normal ranges, but cho- 
linesterase (ChE) was reduced and the serum total 
protein (TP) level was reduced in many patients, 
suggesting nutritional inadequacy. Immunological 
examinations showed increases in whole haemolytic 
complement (CH50) level in seven of the 15 patients. 
Autoantibodies were negative except for two cases, 
who were positive for rheumatoid factor (RA test). 
The PPD test was performed in 15 patients, and 
11 proved negative, suggesting decreases in cell- 
mediated immunity. However, immunoglobulin or 
y-globulin was not reduced in any patient. 
Concerning histopathologic findings, the patients 
could be divided into two groups according to the 
nature of Masson bodies, most importantly due to 
the presence or absence of fibrin in these bodies 
(Table 3). First, in the five fibrin-positive cases, the 
degree of organization of Masson bodies varied 
widely from slight to advanced fibrosis, showing 
proliferation of fibroblast-like cells and increase in 
collagen fibres [Plate l(a)], accompanied by fibrotic 
thickening in the surrounding alveolar walls. Cells in 
Masson bodies included mainly macrophages, lym- 
phocytes and plasma cells, in addition to bipolar 
and long spindle-shaped fibroblast-like cells. Some 
Masson bodies were covered by type II epithelium, 
connecting with other Masson bodies in adjacent 
alveoli through Kohn’s pores. Fibrin in Masson 
bodies was stained by PTAH in the early stage, but 
later on PTAH stained positive in the cytoplasm of 
long spindle-shaped cells arranged concentrically in 
Masson bodies [Plate l(b)]. It is of interest that 
anti-m-actin and anti-a-sm-actin antibodies were 
positive in the cytoplasm of these cells [Plate l(c)], so 
that the cells are considered to have properties of 
myofibroblasts. In Masson bodies showing advanced 
organization, mature collagen fibres stained blue with 
Azan were increased, but no elastic fibres were 
involved in Masson bodies, as revealed by EVG 
staining. In 14 fibrin-negative cases, multipolar pro- 
liferative cells in Masson bodies were sparsely distrib- 
uted and were rich in myxoid matrix [Plate 2(a)]. 
Surrounding interalveolar septa were similarly thick- 
ened. By AB staining, the matrix at Masson bodies 
was intensely stained [Plate 2(b)]. Anti-EMA anti- 
body staining was linearly positive in the portions of 
the surface of the surrounding alveoli but not that of 
Masson bodies [Plate 2(c)]. In addition, these cells 
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Table 4 Interrelationship between effects of steroid 
therapy and types of Masson bodies 
Type 1 Type II 
Shadows in 
chest X-ray 
after steroid 
therapy 
Disappeared 
Improved but 
not disappeared 
11111 o/5 
o/11 515 
were negative for antibodies to m-actin or a-sm-actin. 
As shown in Table 3, bindings in the two groups were 
similar except for the presence or absence of fibrin, 
and there were no particular changes. However, 
inflammation varied widely according to the degree 
of organization in fibrin-positive patients, possibly 
because of the time difference of sampling. Therefore, 
we pathologically classify Masson bodies into two 
types. The patients with fibrin-negative and a-sm- 
actin negative Masson bodies were defined as type I, 
and those with fibrin positive or a-sm-actin positive 
Masson bodies as type II. 
Steroids were administered to 14 of the 16 patients 
who could be followed after TBLB, and two were 
observed without treatment. The chest shadows after 
treatment were followed up with chest X-ray and 
high resolution CT-scan. The shadows disappeared 
within 2 months in 11 of the 16 patients, but they 
persisted in five patients despite steroid therapy. The 
relationship between histopathologic findings and 
treatment was evaluated. A correlation was observed 
between the types of Masson bodies and the effec- 
tiveness of steroids. The chest shadows disappeared 
completely in all type I patients with or without 
steroid therapy, but the effects of steroids were 
not sufficient in type II patients and the shadows 
persisted (Table 4). 
Discussion 
Organizing pneumonitis is a pathologic diagnosis 
made on the basis of histological findings. Clinically, 
it refers to a condition in which fibrin-containing 
effusion in the alveolar cavity is organized due to 
disturbances of the healing process of bronchopneu- 
monia or lobar pneumonia. The disease is generally 
called persistent pneumonia (3,4), but hypersensitiv- 
ity pneumonitis and inflammation or neoplasm are 
often accompanied by OP as a partial phenomenon 
around the lesions. In our patients, some acute 
clinical symptoms and fever were observed, infiltra- 
tion or mixed shadows were observed in chest radio- 
grams, and bacteriological examination was negative. 
The patients were sero-negative for chlamydia and 
mycoplasma, there was no occupational history, 
history of keeping pets, environmental factors, or 
history of the use of particular drugs, and the rela- 
tionship between OP and underlying diseases was not 
clear. Therefore, these patients were diagnosed as 
having COP (1). 
According to our data, a reduction in cholines- 
terase and poor nutritional state were often observed, 
so reduced host defence is considered to be a factor 
in COP. In addition, the complement level was 
increased and PPD tests were negative in many 
patients, suggesting that cell-mediated immunity is 
impaired. Peripheral leucocytosis was not observed in 
many of our patients, but signs of acute inflammation 
such as fever and increases in ESR and CRP were 
observed in all patients, as reported by other authors 
(1,2,5-9). Investigation for autoantibodies was 
negative in all patients, unlike idiopathic interstitial 
pneumonia. LDH was also normal. 
The literature about pathological investigations of 
OP is scarce (1,2,6). In particular, there is only the 
report of Manabe et al. (10) concerning Masson 
bodies in OP. These authors suggested that there are 
two different processes of fibrosis regardless of the 
site of the focus of fibrosis. According to them, the 
degree of fibrosis varies widely, fibrin is present, and 
fibrosis progresses with fibrin clots serving as the 
matrix in genuine OP, showing precipitation and 
organization of fibrin in alveoli around lung 
abscesses. On the other hand, in OP observed in 
BOOP, fibrin plays little or no role, and the disease 
begins with sparse growth of connective tissue. Our 
study also confirmed the presence of two types of 
Masson bodies in COP. In type II Masson bodies, 
fibrosis was diverse and fibrin persisted. This condi- 
tion is considered to correspond to genuine OP 
described by Manabe et al. (10). The fibroblast-like 
cells observed in this condition are positive for PTAH 
staining in the cell body and reacted with antibodies 
to vimentin, muscle-actin and a-sm-actin so that they 
are suspected to have properties of myofibroblasts. 
The growth of these cells is considered to be import- 
ant in this type of Masson body organization. On 
the other hand, type I Masson bodies that showed 
sparse fibrosis were rich in AB-positive mucopoly- 
saccharide matrix, and did not contain or have a 
relationship to fibrin. Bipolar or multipolar cells 
observed in such Masson bodies do not show distinct 
characteristics of fibroblasts or myofibroblasts, and 
are considered to be immature mesenchymal cells. 
What causes the differences in these two types of 
Masson bodies? The period from the onset of symp- 
toms to the diagnosis was 6 f 4.1 days (mean f SD) in 
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type I patients and 12.8 f 12.5 days (mean f SD) in 
type II patients, which is not significantly different. 
Therefore, the differences in these two types of 
Masson bodies cannot be explained by the duration 
of illness. Katzenstein et al. (5) speculated that BOOP 
is caused by infection, especially viral. In our study, 
signs of inflammation were more marked in type II 
patients than in type I. The differences in these two 
types may only be caused by the magnitude of the 
insult. However, Masson bodies in type I closely 
resembled those occasionally observed in eosinophilic 
pneumonia and hypersensitivity pneumonitis, and 
Masson bodies in type II closely resembled those 
in pneumonia. Therefore, we believe that type I COP 
is caused by allergy and that type II COP by 
infection. 
There are various reports on treatments for COP 
(1,8,11). Davison et al. (1) reported that COP 
responded well to steroids, but steroids are ineffective 
or worsen the condition in some patients. King et al. 
(11) reported the treatment outcome and prognosis 
on 96 subjects with COP, with complete remission in 
63% of patients and partial remission in 31% of 
patients. In our study, steroids were effective in all 
patients. In particular, shadows disappeared from 
chest radiograms in all patients with type I Masson 
bodies after steroid therapy or without treatment. 
However, the shadows invariably persisted in all 
patients with type II Masson bodies despite steroid 
therapy, though they were reduced in size in some 
patients. These findings suggest a close relationship 
between the process of formation of Masson bodies 
in COP and the effects of steroids. This relationship 
has not been reported previously. 
Recently, attempts at clinical classification of 
BOOP have been reported. Cordier et al. (7) divided 
patients with BOOP into those who showed multiple 
patchy shadows in chest X-rays (group l), those who 
showed solitary shadows (group 2) and those with 
interstitial shadows (group 3). This study found that 
the outcome was favourable despite severe signs of 
inflammation such as cough, fever, and increased 
erythrocyte sedimentation rate in group 1. However, 
dyspnoea was severe and the outcome poor in some 
patients of group 3. We would suggest the pathologi- 
cal classification of COP and BOOP into two types 
according to the presence or absence of fibrin and to 
a positive or negative reaction of a-sm-actin antibody 
in Masson bodies, rather than by chest X-ray find- 
ings. The group with fibrin-negative, a-sm-actin 
negative Masson bodies is defined as type I, and the 
group with fibrin-positive or a-sm-actin positive 
Masson bodies as type II. Differences in clinical 
symptoms and chest X-ray findings between the two 
groups must still be clarified. However, this classifi- 
cation allows distinction of two groups of patients 
different in pathologic findings, responses to steroids 
and prognosis, and suggests two different disease 
types, Since epithelial injury is similar in BOOP, 
acute interstitial pneumonia (AIP) and usual intersti- 
tial pneumonia (UIP), Myers and Katzenstein (12) 
considered that both diseases are caused by acute 
epithelial injury. Fibroblasts and myofibroblasts are 
considered to migrate into alveoli because of this 
epithelial injury and deposit organizing effusions 
(13,14). According to Myers and Katzenstein, while 
this epithelial injury is localized around the airway in 
BOOP, it extends widely to the lung periphery in UIP 
and AIP, hence differences in clinical symptoms and 
prognosis (12). In contrast, we suspect that differ- 
ences in the process of organization according to the 
presence or absence of fibrin in Masson bodies are 
responsible for differences in clinical symptoms and 
prognosis. 
From these observations, we conclude that there 
are two types of organization in COP and BOOP. 
Type I is unexplained fibrosis, characterized by an 
abundance of myxiod matrix in which fibrin is not 
present or involved. It responds well to steroids, 
shadows in chest radiograms are shortly resolved and 
the prognosis is favourable. Type II is fibrosis which 
involves fibrin and the character of the fibroblast-like 
cells is very similar to that of myofibroblasts. It 
responds poorly to steroids and resolution of shad- 
ows in chest radiograms is delayed. The fact that the 
outcome of COP and BOOP can be estimated by 
histopathological examination of TBLB specimens is 
considered to be good news for clinicians. 
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